Clinical trial
Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients…
NCT00417222 · Tohoku University, Other · Completed
Key facts
| NCT number | NCT00417222 |
|---|---|
| Title | Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan |
| Official title | Supplemental Benefit of Angiotensin II Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan (SUPPORT Trial) |
| Acronym | SUPPORT |
| Lead sponsor | Tohoku University, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Heart Failure |
| Intervention type | Drug |
| Interventions | olmesartan medoxomil |
| Enrollment | 1,145 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | Dec 29, 2006 |
| Last update posted | May 19, 2014 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: